RxDoctor Payments Data

Katherine Mendez Martinez

Family · North Miami Beach, FLNPI 1598211740

Payments from drug & device makers

$4,931in general payments, 2019–2025

Across 208 payments — averaging $23.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$689
  • AstraZeneca$441
  • Boehringer Ingelheim$425
  • Exact Sciences$346
  • AbbVie$303
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,931100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,931 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin26$24,466
OzempicSemaglutide14$21,774
LinzessLinaclotide11$12,778
Diclofenac Sodium22$692
Rosuvastatin Calcium26$688
Atorvastatin Calcium45$367
Ezetimibe11$276
Losartan Potassium44$201
Cyclobenzaprine Hcl13$179
Amlodipine Besylate21$171
Nifedipine ErNifedipine11$141
ClopidogrelClopidogrel Bisulfate17$141
Gabapentin13$120
Simvastatin25$109
Metformin Hcl32$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$425$24,46626 claims
Novo NordiskOzempic$1,056$21,77414 claims
AbbVieLinzess$303$12,77811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.

Other family in North Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →